OTCM
IMPZY
Market cap199mUSD
Sep 21, Last price
0.08USD
Name
Implanet SA
Chart & Performance
P/E
—
P/S
1.20
EPS
—
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
2.19%
Revenues
7m
Net income
-7m
CFO
-1m
Dividend
Apr 24, 20240.9964 USD/sh
Profile
Implanet S.A., together with its subsidiaries, researches and develops, manufactures, and sells spinal and orthopedic implants. The company offers spinal and knee products. Its products include Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, Jazz Frame, and ISS-Jazz Screw systems for posterior fixation. The company also provides knee prostheses under the Madison name. Implanet S.A. has a strategic partnership with Shanghai Sanyou Medical Co, Ltd. The company was founded in 2006 and is based in Martillac, France.
Valuation
Title EUR in thousands, except ratios and share amounts | FY |
|---|---|
| 2023‑12 | |
| Income | |
Revenues | 7,447 |
Cost of revenue | 7,286 |
Unusual Expense (Income) | |
NOPBT | 161 |
NOPBT Margin | 2.16% |
Operating Taxes | |
Tax Rate | |
NOPAT | 161 |
Net income | (6,676) |
Dividends | |
Dividend yield | |
Proceeds from repurchase of equity | 3,546 |
BB yield | |
| Debt | |
Debt current | 4,477 |
Long-term debt | 2,301 |
Deferred revenue | |
Other long-term liabilities | 171 |
Net debt | 6,530 |
| Cash flow | |
Cash from operating activities | (1,447) |
CAPEX | (298) |
Cash from investing activities | (768) |
Cash from financing activities | 1,949 |
FCF | |
| Balance | |
Cash | 248 |
Long term investments | |
Excess cash | |
Stockholders' equity | (6,266) |
Invested Capital | 12,414 |
ROIC | 1.30% |
ROCE | 2.62% |
| EV | |
Common stock shares outstanding | 38,900 |
Price | |
Market cap | |
EV | |
EBITDA | 1,470 |
EV/EBITDA | |
Interest | 268 |
Interest/NOPBT | 166.46% |